Epidemiology of hepatitis C in the United States

American Journal of Medicine

Volumn 107, Issue 6 SUPPL. 2, 1999, Pages 2-9

  Williams, Ian ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DISEASE TRANSMISSION; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; INTRAVENOUS DRUG ABUSE; MORTALITY; PATIENT INFORMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; VIRUS TRANSMISSION;

EID: 0033382086     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00373-3     Document Type: Conference Paper

References (29)

1. Choo Q.L., Kuo G., Weiner A.J., et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Purcell R. The hepatitis C virus overview . Hepatology. 26:(2 suppl 1):1997;11S-14S.
3. Farci P., Alter H.J., Govindarajan S., et al. Lack of protective immunity against reinfection with hepatitis C virus. Science. 258:1992;135-140.
4. Aach R.D., Stevens C.R., Hollinger F.B., et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med. 325:1991;1325-1329.
5. Koretz R.L., Brezina M., Polito A.J., et al. Non-A, non-B posttransfusion hepatitis comparing C and non-C hepatitis . Hepatology. 17:1993;361-365.
6. Seeff L.B. Natural history of hepatitis C. Hepatology. 26:(3 suppl 1):1997;21S-28S.
7. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology. 1997;26(2 suppl 1):2S-10S.
8. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C (HCV) infection and HCV-related chronic disease. MMWR. 1998;47: (RR = 19):1-38.
9. Schreiber G.B., Busch M.P., Kleinman S.H., et al. The risk of transfusion-transmitted viral infections. N Engl J Med. 334:1996;1685-1690.
10. Garfein R.S., Vlahov D., Galai N., Doherty M.C., Nelson K.E. Viral infections in short-term injection drug users the prevalence of the hepatitis C, hepatitis B, immunodeficiency, and human T-lymphotropic viruses . Am J Public Health. 86:1996;655-661.
11. Conry-Cantilena C., Vanraden M., Gible J., et al. Routes of infection, viremia and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 334:1996;1691-1696.
12. Alter M.J. Epidemiology of hepatitis C. Hepatology. 26:1997;62S-65S.
13. Alter M.J., Gerety R.J., Smallwood L., et al. Sporadic non-A, non-B hepatitis frequency and epidemiology in an urban United States population . J Infect Dis. 145:1982;886-893.
14. Alter M.J., Coleman P.J., Alexander W.J., et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA. 262:1989;1201-1205.
15. Osmond D.H., Charlebois E., Shappard H.W., et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis. 167:1993;66-71.
16. Weinstock H.S., Bolan G., Eringold A.L., Polich L.B. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA. 269:1993;392-394.
17. Thomas D.L., Cannon R.O., Shapiro C.N., et al. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis. 169:1994;990-995.
18. Buchbinder S.P., Katz M.H., Hessol N.A., et al. Hepatitis C virus infection in sexually active homosexual men. J Infect. 29:1994;263-269.
19. Thomas D.L., Zenilman J.M., Alter H.J., et al. Sexual transmission of hepatitis C virus among patients attending Baltimore sexually transmitted diseases clinics an analysis of 309 sex partnerships . J Infect Dis. 171:1995;768-775.
20. Mast EE, Darrow WW, Witte J, et al. Hepatitis C virus infection among prostitutes: evidence for sexual transmission and protective efficacy of condoms. Program and Abstracts of the Third International Symposium on HCV, Strasbourg, France, 1991:95. Abstract.
21. Everhart J.E., DiBisceglie A.M., Murray L.M., et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med. 112:1990;544-545.
22. Eyster M.E., Alter H.J., Aledort L.M., et al. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med. 115:1991;764-768.
23. Gordon S.C., Patel A.H., Kulseza G.W., et al. Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol. 87:1992;1849-1851.
24. Tong M.J., Lai P.P.C., Hwang S.-J., et al. Evaluation of sexual transmission in patients with hepatitis C infection. Clin Diag Virology. 3:1995;39-47.
25. Frieden T.R., Ozick L., McCord C., et al. Chronic liver disease in central Harlem the role of alcohol and viral hepatitis . Hepatology. 29:1999;883-887.
26. Alter M.J., Kruszon-Moran D., Nainan O.V., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 341:1999;556-562.
27. Koff R.S., Dienstag J.L. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis. 15:1995;101-109.
28. Yoshihara H., Noda K., Kamada T. Interrelationship between alcohol intake, hepatitis C, liver cirrhosis, and hepatocellular carcinoma. Recent Dev Alcoholism. 14:1998;457-469.
29. FDA Document Guidance for Industry. Current Good Manufacturing Practice for Blood and Blood Components: (1) Quarantine and Disposition of Units from Prior Collections from Donors with Repeatedly Reactive Screening Tests for Antibody to Hepatitis C Virus (Anti-HCV); (2) Supplemental Testing, and the Notification of Consignees and Blood Recipients of Donor Test Results for Anti-HCV. (This document is available on the Internet at http://www.fda.gov/cber/gdlns/gmphcv.txt.).